<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A type I ribosome inactivating protein, gelonin, was linked to Lym-1, a murine monoclonal antibody reactive with a polymorphic determinant of class II HLA-DR histocompatibility leukocyte antigen (HLA) on human <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells, via a <z:chebi fb="0" ids="48343">disulfide</z:chebi> linkage using the heterobifunctional cross-linking agent, N-succinimidyl-3-(2-pyridyldithio) <z:chebi fb="0" ids="17272">propionate</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>This immunotoxin was purified from unreacted gelonin and unconjugated Lym-1 by fast protein liquid chromatography using sephacryl S-300 gel filtration and blue <z:chebi fb="0" ids="2511">sepharose</z:chebi> affinity gradient separation </plain></SENT>
<SENT sid="2" pm="."><plain>Binding of Lym-1-gelonin immunoconjugate to human Raji Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells was demonstrated by indirect immunofluorescence using flow cytometry </plain></SENT>
<SENT sid="3" pm="."><plain>Lym-1-gelonin was very active in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium salt and <z:chebi fb="0" ids="52101">sulforhodamine B</z:chebi> in vitro cytotoxicity assays against the Raji <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line and confirmed the fact that monoclonal antibody Lym-1 internalizes into human <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
<SENT sid="4" pm="."><plain>A weaker <z:chebi fb="0" ids="35610">cytostatic</z:chebi> antiproliferative effect was also noted for unconjugated Lym-1 </plain></SENT>
<SENT sid="5" pm="."><plain>gamma-interferon augmented the antiproliferative effects of Lym-1-gelonin conjugate and unconjugated Lym-1, by having a direct cytotoxic effect on the Raji cells </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha also enhanced the antiproliferative effect of unconjugated Lym-1, but did not significantly augment the cytotoxic activity of the Lym-1-gelonin conjugate </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that anti-HLA class II monoclonal antibodies may be useful in constructing immunotoxins for the treatment of human <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and <z:hpo ids='HP_0001909'>leukemias</z:hpo> expressing HLA class II antigens, and that unconjugated anti-HLA class II monoclonal antibodies may be therapeutically useful in conjunction with recombinant cytokines, especially gamma-interferon </plain></SENT>
</text></document>